REQUEST A DEMO
Total
USD $0.00
Search more companies

Frey Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Food Manufacturing | Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Department Stores | Warehousing and Storage | Internet Publishing and Broadcasting and Web Search Portals
Full name: Frey Pharma Sp. z o.o. Profile Updated: May 19, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Frey Pharma Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was incorporated on May 18, 2020. The latest financial highlights indicate a net sales revenue drop of 61.18% in 2023. Its total assets grew by 22.03% over the same period. The net profit margin of Frey Pharma Sp. z o.o. decreased by 5.2% in 2023.

Headquarters
Ul. Al. Aleje Jerozolimskie 109/70
Warsaw; Mazowieckie; Postal Code: 02-011

Contact Details: Purchase the Frey Pharma Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Frey Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Frey Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 18, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Frey Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-61.18%
Total Operating Revenue
-61.18%
Operating Profit
-65.77%
Net Profit/Loss for the Period
-66.06%
Total Assets
22.03%
Total Equity
103.94%
Operating Profit Margin
-5.42%
Net Profit Margin
-5.2%
Return on Equity (ROE)
-255.31%
Debt / Equity
-345.15%
Quick Ratio
0.12%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?